217 related articles for article (PubMed ID: 12186960)
1. Detecting regional cerebral blood flow changes in Alzheimer's patients after milameline treatment: activation or baseline SPECT?
Zheng XM
J Nucl Med Technol; 2002 Sep; 30(3):118-22. PubMed ID: 12186960
[TBL] [Abstract][Full Text] [Related]
2. Combined cerebral blood flow effects of a cholinergic agonist (milameline) and a verbal recognition task in early Alzheimer's disease.
Trollor JN; Sachdev PS; Haindl W; Brodaty H; Wen W; Walker BM
Psychiatry Clin Neurosci; 2006 Oct; 60(5):616-25. PubMed ID: 16958947
[TBL] [Abstract][Full Text] [Related]
3. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique.
Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H
J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830
[TBL] [Abstract][Full Text] [Related]
4. Memory-provoked rCBF-SPECT as a diagnostic tool in Alzheimer's disease?
Sundström T; Elgh E; Larsson A; Näsman B; Nyberg L; Riklund KA
Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):73-80. PubMed ID: 16151770
[TBL] [Abstract][Full Text] [Related]
5. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
Varrone A; Pappatà S; Caracò C; Soricelli A; Milan G; Quarantelli M; Alfano B; Postiglione A; Salvatore M
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1447-54. PubMed ID: 12397463
[TBL] [Abstract][Full Text] [Related]
6. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J
J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621
[TBL] [Abstract][Full Text] [Related]
7. Memory functions and rCBF (99m)Tc-HMPAO SPET: developing diagnostics in Alzheimer's disease.
Elgh E; Sundström T; Näsman B; Ahlström R; Nyberg L
Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1140-8. PubMed ID: 12192558
[TBL] [Abstract][Full Text] [Related]
8. Effect of linearization correction on statistical parametric mapping (SPM): a 99mTc-HMPAO brain perfusion SPECT study in mild Alzheimer's disease.
Ansar MA; Osaki Y; Kazui H; Oku N; Takasawa M; Kimura Y; Begum NN; Ikejiri Y; Takeda M; Hatazawa J
Ann Nucl Med; 2006 Oct; 20(8):511-7. PubMed ID: 17134017
[TBL] [Abstract][Full Text] [Related]
9. Regional cerebral blood flow measured by 99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease.
Soininen H; Helkala EL; Kuikka J; Hartikainen P; Lehtovirta M; Riekkinen PJ
J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):95-109. PubMed ID: 8527009
[TBL] [Abstract][Full Text] [Related]
10. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT.
Kogure D; Matsuda H; Ohnishi T; Asada T; Uno M; Kunihiro T; Nakano S; Takasaki M
J Nucl Med; 2000 Jul; 41(7):1155-62. PubMed ID: 10914904
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities in rCBF and computed tomography in patients with Alzheimer's disease and in controls.
Wyper D; Teasdale E; Patterson J; Montaldi D; Brown D; Hunter R; Graham D; McCulloch J
Br J Radiol; 1993 Jan; 66(781):23-7. PubMed ID: 8428246
[TBL] [Abstract][Full Text] [Related]
13. Characteristic deterioration of ADAS-Jcog subscale scores and correlations with regional cerebral blood flow reductions in Alzheimer's disease.
Yoshii F; Kawaguchi C; Kohara S; Shimizu M; Onaka H; Ryo M; Takahashi W
Neurol Sci; 2018 May; 39(5):909-918. PubMed ID: 29508099
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-HMPAO regional cerebral blood flow and quantitative electroencephalography in Alzheimer's disease: a correlative study.
Rodriguez G; Nobili F; Copello F; Vitali P; Gianelli MV; Taddei G; Catsafados E; Mariani G
J Nucl Med; 1999 Apr; 40(4):522-9. PubMed ID: 10210209
[TBL] [Abstract][Full Text] [Related]
15. SPECT for differential diagnosis of dementia and correlation of rCBF with cognitive impairment.
Osimani A; Ichise M; Chung DG; Pogue JM; Freedman M
Can J Neurol Sci; 1994 May; 21(2):104-11. PubMed ID: 8087734
[TBL] [Abstract][Full Text] [Related]
16. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease.
Nakano S; Asada T; Matsuda H; Uno M; Takasaki M
J Nucl Med; 2001 Oct; 42(10):1441-5. PubMed ID: 11585854
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: a SPECT blood flow study.
Brown DR; Hunter R; Wyper DJ; Patterson J; Kelly RC; Montaldi D; McCullouch J
J Psychiatr Res; 1996; 30(2):109-26. PubMed ID: 8816305
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the regional cerebral blood flow changes during long-term donepezil therapy in patients with Alzheimer's disease using 3DSRT.
Kimura N; Kumamoto T; Masuda T; Hanaoka T; Okazaki T; Arakawa R
J Neuroimaging; 2012 Jul; 22(3):299-304. PubMed ID: 21699607
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease.
Matsuda H; Kitayama N; Ohnishi T; Asada T; Nakano S; Sakamoto S; Imabayashi E; Katoh A
J Nucl Med; 2002 Mar; 43(3):304-11. PubMed ID: 11884488
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-HMPAO SPECT study of cerebral perfusion after treatment with medication and electroconvulsive therapy in major depression.
Kohn Y; Freedman N; Lester H; Krausz Y; Chisin R; Lerer B; Bonne O
J Nucl Med; 2007 Aug; 48(8):1273-8. PubMed ID: 17631560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
